| Identification | Back Directory | [Name]
-Trimethoxyflavone | [CAS]
720675-74-1 | [Synonyms]
4'
6,2'
-Trimethoxyflavone
2-(2,4-dimethoxyphenyl)-6-methoxy-4H-chromen-4-one
4H-1-Benzopyran-4-one, 2-(2,4-dimethoxyphenyl)-6-methoxy- | [Molecular Formula]
C18H16O5 | [MOL File]
720675-74-1.mol | [Molecular Weight]
312.32 |
| Chemical Properties | Back Directory | [Boiling point ]
495.211±45.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.243±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [solubility ]
Soluble to 5 mM in DMSO with gentle warming | [form ]
Powder | [color ]
Yellow to orange |
| Hazard Information | Back Directory | [Description]
Aryl hydrocarbon receptor antagonist (EC50= 0.9μM). Exhibits no short term agonist activity and no species or promoter dependence. | [Uses]
Biofilm inhibition activity of 6,2',4'-Trimethoxyflavone was studied. Potential therapeutic applications as an antibiofilm agent. | [in vivo]
6,2',4'-trimethoxyflavone-treated (5 mg/kg/day; i.p.) WT mice shows significantly decreased infarct volume, improved sensorimotor, and nonspatial working memory functions compared with their respective controls[3]. | Animal Model: | Male C57BL/6 wild-type (WT) mice, AHRcKO mice[3] | | Dosage: | 5 mg/kg/day | | Administration: | I.p. | | Result: | Both TMF-treated and AHRcKO mice attenuated acute cerebral infarction and functional impairments.
|
|
|
|